Treatment of fetal supraventricular tachycardia with flecainide acetate after digoxin failure.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1909841.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transplacentally administered digoxin is the drug of choice for the treatment of fetal supraventricular tachycardia. We describe a case of fetal supraventricular tachycardia associated with fetal hydrops that did not respond to digoxin treatment because of a lack of transplacental passage. In contrast, flecainide acetate crossed the placenta and cured the fetus. The clinical implications of this new treatment are discussed.
Medical subject headings
- Digoxin
- Fetal Diseases
- Flecainide
- Tachycardia, Supraventricular